Lynch Syndrome (Hereditary colorectal cancer)


GEC-KO on the run: A 3-page, evidence-based summary for healthcare providers.  Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing. (Updated Jan 2019)

GEC-KO Messenger: A 9-page, comprehensive evidence-based resource for healthcare providers.  Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing, references and more.  (Updated Jan 2019)

Point of care tool: A two-part (I, II) tool containing three questions to stratify an individual’s risk for hereditary colorectal cancer and to identify those that likely to benefit from a genomic assessment (I), as well as those at high risk to carry a mutation in a Lynch syndrome gene (II).   (Updated Oct 2014).

GEC-KO aims to aid the practicing non-genetics health professional by providing informed opinions regarding genetic/genomic conditions, services and technologies that have been developed in a rigorous and evidence-based manner with periodic updating.  The content on the GEC-KO site is for educational purposes only.  No resource should be used as a substitute for clinical judgement.  GEC-KO assumes no responsibility or liability resulting from the use of information contained herein.